Retina disease injection a thing of the past?
September 17th 2007Intravitreal injections for the treatment of retinal diseases, such as neovascular age-related macular degeneration (AMD), could be replaced by a non-invasive gel formulation, applied under the eyelid, according to a presentation made at this month's meeting of the British Royal Pharmaceutical Society in Manchester, UK.
Improving astigmatism correction with a rotation-stable, bitoric, aspherical IOL and coaxial MICS
September 11th 2007Implantation of the bitoric, aspherical intraocular lens (IOL), *Acri.Comfort 646 TLC (*Acri.Tec), is rotation-stable and associated with excellent levels of astigmatism correction in cataract patients.
Signature phaco machine offers good stability
September 11th 2007Anterior chamber fluctuations during phacoemulsification can cause an increase in retinal thickness and alterations of the blood aqueous barrier. In order to avoid these complications, it is better to use a machine that offers good anterior chamber stability.
IOL type determines complications in phakic surgery
September 11th 2007The type of phakic IOL chosen strongly governs the type of complication that is likely to occur in the long-term. Posterior, angle-supported anterior and iris supported anterior phakic IOLs all have different issues that face the surgeon.
Refractive surgery will disappear to be replaced by RLE
September 10th 2007Dr Howard I. Fine told delegates that he was the best ophthalmic surgeon because none of his patients used glasses. He then showed the audience a video of 'patients', all wearing spectacles, drinking directly from bottles of wine. It was a lighted finish in keeping to the session's theme, "I am the best because. . .".
A few simple changes can dramatically reduce endophthalmitis
September 10th 2007Changes to perioperative management of cataract patients, including the use of disposable bimanual irrigation/aspiration handpieces, intracameral cefuroxime and povidone iodine wash can be effective in reducing the instances of endophthalmitis.
Endophthalmitis: sterile unit cefuroxime dose needed
September 10th 2007If a sterile unit dose of cefuroxime were available it would become the world standard for endophthalmitis prophylaxis following the startling proof of its efficacy in the ESCRS endophthalmitis study last year. That was the conclusion of a debate for and against intracameral antibiotics at the JCRS Symposium, Controversies in Cataract & Refractive Surgery.